Marie Newman bought Novocure Ltd (NASDAQ: NVCR)
Marie Newman (D-IL), a U.S. Representative, has disclosed 1 trade in Novocure Ltd (NVCR) since 2021, a single purchase, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Marie Newman bought $15,001 - $50,000 of Novocure Ltd (NASDAQ: NVCR) on July 2, 2021. Since that trade, NVCR is down -91.73% against the S&P 500 up +82.50%, an outperformance of -174.23%.
Data updated
Marie Newman's NVCR trades vs the price
NVCR is down -91.73% since Marie Newman bought on July 2, 2021, versus +82.50% for the S&P 500.
Performance since this trade
All Marie Newman NVCR trades
Marie Newman & NVCR trading FAQ
Is it legal for Marie Newman to trade Novocure Ltd (NVCR) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Novocure Ltd (NVCR), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Marie Newman buy NVCR?
Marie Newman disclosed a purchase of $15,001 - $50,000 of Novocure Ltd (NVCR) on July 2, 2021, according to public STOCK Act filings.
How has NVCR performed since Marie Newman's trade?
Since Marie Newman bought NVCR on July 2, 2021, the stock is down -91.73%, versus +82.50% for the S&P 500 over the same period, an outperformance of -174.23%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional NVCR trades?
Quantellect tracks every disclosed congressional trade in Novocure Ltd (NVCR) on the Novocure Ltd congressional trading page, which aggregates filings across all members of Congress.
Marie Newman's NVCR tradesAll congressional filings for Novocure LtdMarie Newman's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.